Skip to search formSkip to main contentSkip to account menu

ABT 102

Known as: ABT-102, ABT102 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

IndazolesUrea
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Title : TRPV 1 receptors in sensitisation of cough and pain reflexes
HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they… 
2013
2013
An oral TRPV1 antagonist attenuates laser radiant‐heat‐evoked potentials and pain ratings from UVB‐inflamed and normal skin
Laser (radiant‐heat) evoked potentials (LEPs) from vertex‐EEG peak‐to‐peak (PtP) amplitude were used to determine acute… 
2012
2012
Pharmacokinetics of the TRPV1 Antagonist ABT‐102 in Healthy Human Volunteers: Population Analysis of Data From 3 Phase 1 Trials
ABT‐102 is a selective TRPV1 antagonist with robust efficacy in several preclinical models of pain. Three phase 1 studies… 
2012
2012
A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid‐Dispersion Formulations of the TRPV1 Antagonist ABT‐102, Relative to the Oral Solution Formulation, in Healthy Human…
ABT‐102 is a selective TRPV1 antagonist designed for treatment of nociceptive pain. The objective of this study was to… 
2010
2010
501 ORAL AND CUTANEOUS THERMOSENSORY PROFILE OF SELECTIVE TRPV1 INHIBITION BY ABT‐102 IN HEALTHY VOLUNTEERS
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)